Gara Jalqabaatti › Kansara Qara'a Non-Small Cell › Illinois › Evanston
Qorannoo klinikaalii Kansara Qara'a Non-Small Cell Evanston, IL keessatti
Qorannoo 22 Kansara Qara'a Non-Small Cell f Evanston fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 2
- Illinois Cancer Specialists /ID# 274678, Niles · Miili 6 fagaatti
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Namoota walitti qabaa jiraSadarkaa 3
- Orchard Healthcare Research Inc. ( Site 0115), Skokie · Miili 2 fagaatti
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Namoota walitti qabaa jiraSadarkaa 3
- NorthShore University HealthSystem-Evanston Hospital, Evanston
- NorthShore University HealthSystem-Glenbrook Hospital, Glenview · Miili 5 fagaatti
- Advocate Lutheran General Hospital, Park Ridge · Miili 8 fagaatti
- fi 1 dabalataa
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Namoota walitti qabaa jiraSadarkaa 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · Miili 5 fagaatti
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Namoota walitti qabaa jiraSadarkaa 3
- Endeavor Health, Evanston
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Namoota walitti qabaa jiraSadarkaa 3
- North Shore University Health System ( Site 4014), Evanston
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Namoota walitti qabaa jiraSadarkaa 3
- Illinois Cancer Specialists, Niles · Miili 6 fagaatti
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Illinois Cancer Specialists, Niles · Miili 6 fagaatti
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Namoota walitti qabaa jiraSadarkaa 3
- Advocate Lutheran General Hospital, Park Ridge · Miili 8 fagaatti
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Namoota walitti qabaa jiraSadarkaa 3
- Clinical Study Site, Evanston
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Namoota walitti qabaa jiraSadarkaa 2/3
- USOR - Illinois Cancer Specialists - Niles, Niles · Miili 6 fagaatti
- Advocate Medical Group Oncology, Park Ridge · Miili 8 fagaatti
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
Namoota walitti qabaa jiraQorannoo ilaalaa
- Orchard Healthcare Research Inc., Skokie · Miili 2 fagaatti
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Niles · Miili 6 fagaatti
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · Miili 5 fagaatti
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Advocate Aurora Health, Park Ridge · Miili 8 fagaatti
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · Miili 5 fagaatti
- Advocate Lutheran General Hospital, Park Ridge · Miili 8 fagaatti
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Evanston
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · Miili 5 fagaatti
- Advocate Lutheran General Hospital, Park Ridge · Miili 8 fagaatti
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2/3
- Northwestern Medicine Glenview Outpatient Center, Glenview · Miili 5 fagaatti
- Advocate Lutheran General Hospital, Park Ridge · Miili 8 fagaatti
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · Miili 5 fagaatti
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Namoota walitti qabaa jiraQorannoo ilaalaa
- Advocate Lutheran General Hospital, Park Ridge · Miili 8 fagaatti
GEMINI-NSCLC: NSCLC Biomarker Study
Namoota walitti qabaa jiraQorannoo ilaalaa
- Northwestern University, Evanston
Qorannoo Kansara Qara'a Non-Small Cell magaalota biroo keessatti
- Houston, TXQorannoo 145
- New York City, NYQorannoo 121
- Arlington, VAQorannoo 104
- Nashville, TNQorannoo 97
- Boston, MAQorannoo 90
- Los Angeles, CAQorannoo 87
- St. Louis, MOQorannoo 73
- Chicago, ILQorannoo 61
- Baltimore, MDQorannoo 60
- San Antonio, TXQorannoo 59
- Columbus, OHQorannoo 57
- Washington, DCQorannoo 55
Qorannoo biroo Evanston keessatti
- Dhibee QaraQorannoo 19
- Saree OljooQorannoo 13
- ObesityQorannoo 12
- Leukemia Myeloidii HamaaQorannoo 11
- Baayyee UlfaataaQorannoo 10
- Kansarii ColorectalQorannoo 10
- Saree (Gosoota Hunda)Qorannoo 9
- Dhukkuba KrooniiQorannoo 9
- Colitis UlcerativeQorannoo 9
- Kansarii ProstateQorannoo 9
- MelanomaQorannoo 8
- Fibrillation AtrialQorannoo 8
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.